Risultati di ricerca
Partecipa al forum sulle Azioni CTi Biopharma (CTIC). Crescita o crollo delle azioni in borsa? cosa fare? scopri opinioni e commenti nella chat live.
CTI BioPharma focuses on the acquisition, development and commercialization of therapies for blood-related cancers that offer unique benefits to patients.
Investing.com - CTi Biopharma (NASDAQ: CTIC) ha riportato nel primo trimestre utili per azione di -0,140 $, 0,04$ sotto le stime degli analisti di -0,097$.
30 mag 2022 · Cell-based therapeutics are an emerging modality with the potential to treat many currently intractable diseases through uniquely powerful modes of action.
3 apr 2013 · Four killer applications for cell-based therapeutics are shown: immune cells engineered to recognize and kill tumor cells, transplanted microbiota that detect and treat intestinal inflammation (e.g., Crohn’s disease) by producing an anti-inflammatory small molecule or biologic, a combination bacterial/mammalian cell therapeutic in which the ...
- Michael A. Fischbach, Michael A. Fischbach, Jeffrey A. Bluestone, Wendell A. Lim
- 2013
1 mar 2022 · Rubius Therapeutics is engineering red blood cells to treat cancer and autoimmune diseases. Learn how its RED PLATFORM technology modifies RBCs to express biotherapeutic proteins and stimulate immune responses.
Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of ...
